ROTTERDAM, NETHERLANDS – The European Public Prosecutor’s Office (EPPO) in Rotterdam has concluded its investigation into an Unnamed individual (Netherlands), issuing a punitive order for significant EU subsidy fraud related to cancer research projects. The individual, whose identity remains undisclosed, was found to have defrauded the EU budget of over €84,000 through falsified invoices and inflated working hours, leading to a sentence of community service and a substantial fine.
The punitive order, handed down on Monday, March 23, 2026, marks a swift resolution to a complex case of financial deception that diverted crucial funds intended for health and innovation within the Eurostars program. This program, co-funded by the EU, is designed to support Small and Medium-sized Enterprises (SMEs) in cutting-edge research.
The Charges: Deception in Cancer Research Funding
The Unnamed individual (Netherlands) was found culpable of EU subsidy fraud, specifically for actions taken on behalf of two now-dissolved companies involved in cancer research. The core of the scheme involved two primary methods of deception:
- Falsified and Reused Invoices: The individual systematically created and resubmitted falsified invoices, artificially inflating the eligible costs of the projects. This allowed for greater reimbursements from the EU than legitimately deserved.
- Over-declaration of Working Hours: A blatant disregard for EU funding rules saw the individual declare working hours that significantly exceeded the stipulated maximum threshold of 1,720 hours, further siphoning funds through fraudulent claims.
These deliberate actions were designed to exploit the Eurostars program, diverting funds intended for genuine scientific advancement to cover the financial shortfalls of the companies involved.
Scale of the Crime: €84,317 Diverted from EU Budget
The estimated damage to the EU budget from this fraud totals a significant €84,317. These funds, earmarked for vital cancer research and innovation, were instead used to prop up the two financially struggling companies. While there are no individual direct victims named, the primary victim is the EU budget itself, and by extension, the broader scientific community and potentially cancer patients who rely on legitimate research funding. The diversion of these funds undermines trust in subsidy programs and impedes critical scientific progress.
Who Is Unnamed individual (Netherlands)?
Public information released by the EPPO has kept the identity of the Unnamed individual (Netherlands) confidential. Details such as age, nationality, and specific profession remain undisclosed. However, it is known that this individual was a key player, acting on behalf of two companies that were actively engaged in cancer research initiatives. Both of these entities have since been dissolved, a consequence that often follows such fraudulent activities.
Investigation Details: EPPO and FIOD Uncover Deception
The intricate web of fraud was first unraveled following an audit conducted by the Dutch Government Audit Service (ADR) in the Province of Limburg. The findings of this audit served as the crucial trigger for the European Public Prosecutor’s Office (EPPO) in Rotterdam to launch its full-scale investigation. The EPPO, the independent public prosecution office of the European Union, led the probe, receiving vital support from the Dutch Fiscal Information and Investigation Service (FIOD).
“The swift resolution of this case through a punitive order underscores the EPPO’s commitment to protecting the EU budget from fraud, even when it involves complex schemes disguised within vital research sectors,” stated an EPPO representative familiar with the case.
What Happens Next: Community Service and a €10,000 Fine
With the conclusion of the investigation, the Unnamed individual (Netherlands) has received a punitive order. This order comprises 60 hours of community service and a fine of €10,000. Significantly, this case did not proceed to a formal trial. The EPPO utilized a simplified prosecution procedure, allowing for a timely resolution and accountability for the criminal conduct without the need for lengthy court proceedings. There are no indications of ongoing investigations related to this specific individual or further charges at this time.
Protecting Yourself: Identifying Red Flags in Grant Funding
This case serves as a stark reminder of the vulnerabilities within grant funding systems and the importance of robust oversight. For organizations and individuals involved in EU-funded projects, several red flags should prompt immediate scrutiny. These include consistently inflated project costs, particularly through the use of questionable or reused invoices, and the declaration of working hours that exceed established maximum thresholds. Related fraud investigations have often highlighted similar patterns.
Furthermore, consistent financial shortfalls within grant-receiving entities should be a warning sign, as desperation can sometimes lead to fraudulent activities. The fact that an audit ultimately uncovered this fraud emphasizes the critical role of regular and thorough external and internal audits. Companies and funding bodies must implement stringent financial controls, comprehensive time-tracking mechanisms, and vigilant oversight to prevent such schemes from taking root and to ensure that valuable research funds are used for their intended, legitimate purposes.
